CN1125068C - 嘌呤衍生物的制备方法 - Google Patents

嘌呤衍生物的制备方法 Download PDF

Info

Publication number
CN1125068C
CN1125068C CN99804402A CN99804402A CN1125068C CN 1125068 C CN1125068 C CN 1125068C CN 99804402 A CN99804402 A CN 99804402A CN 99804402 A CN99804402 A CN 99804402A CN 1125068 C CN1125068 C CN 1125068C
Authority
CN
China
Prior art keywords
alkyl
compound
general formula
aryl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN99804402A
Other languages
English (en)
Chinese (zh)
Other versions
CN1294591A (zh
Inventor
G·R·格恩
A·C·沙雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Novartis International Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis International Pharmaceutical Ltd filed Critical Novartis International Pharmaceutical Ltd
Publication of CN1294591A publication Critical patent/CN1294591A/zh
Application granted granted Critical
Publication of CN1125068C publication Critical patent/CN1125068C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN99804402A 1998-04-02 1999-03-30 嘌呤衍生物的制备方法 Expired - Fee Related CN1125068C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9807116.0A GB9807116D0 (en) 1998-04-02 1998-04-02 Novel process
GB9807116.0 1998-04-02

Publications (2)

Publication Number Publication Date
CN1294591A CN1294591A (zh) 2001-05-09
CN1125068C true CN1125068C (zh) 2003-10-22

Family

ID=10829765

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99804402A Expired - Fee Related CN1125068C (zh) 1998-04-02 1999-03-30 嘌呤衍生物的制备方法

Country Status (16)

Country Link
US (1) US6437125B1 (https=)
EP (1) EP1068210B1 (https=)
JP (1) JP4459439B2 (https=)
KR (1) KR100613812B1 (https=)
CN (1) CN1125068C (https=)
AT (1) ATE268332T1 (https=)
AU (1) AU3605199A (https=)
BR (1) BR9908959A (https=)
CA (1) CA2323965A1 (https=)
DE (1) DE69917765T2 (https=)
DK (1) DK1068210T3 (https=)
ES (1) ES2222702T3 (https=)
GB (1) GB9807116D0 (https=)
IL (1) IL138289A0 (https=)
PT (1) PT1068210E (https=)
WO (1) WO1999051604A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60202245T2 (de) 2001-08-30 2005-09-01 Ajinomoto Co., Inc. Herstellungsmethode von Famciclovir und Herstellungs- bzw. Kristallisationsmethode eines entsprechenden Intermediates
AU2003268213A1 (en) * 2002-08-26 2004-03-11 Teva Pharmaceutical Industries Ltd. Crystalline solid famciclovir forms i, ii, iii and preparation thereof
US7473780B2 (en) * 2004-05-18 2009-01-06 Teva Pharmeceutical Industries Ltd. Drying process for preparing crystalline solid famciclovir
GB2426247A (en) * 2005-05-20 2006-11-22 Arrow Int Ltd Methods of preparing purine derivatives such as famciclovir
CN110386935A (zh) * 2018-04-20 2019-10-29 重庆常捷医药有限公司 一种泛昔洛韦中间体的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
US5684153A (en) * 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
EP0182024B1 (en) * 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use
GB8817607D0 (en) 1988-07-23 1988-09-01 Beecham Group Plc Novel process
US5688948A (en) * 1991-09-18 1997-11-18 Ajinomoto Co., Inc. Process for isomerizing acyclic nucleosides and process for separating purine nucleosides
GB9407698D0 (en) * 1994-04-19 1994-06-15 Smithkline Beecham Plc Pharmaceuticals
EP0827960A1 (en) * 1996-09-10 1998-03-11 Ajinomoto Co., Inc. Process for producing purine derivatives

Also Published As

Publication number Publication date
PT1068210E (pt) 2004-10-29
WO1999051604A3 (en) 2000-02-17
CN1294591A (zh) 2001-05-09
AU3605199A (en) 1999-10-25
JP2002510692A (ja) 2002-04-09
DE69917765D1 (de) 2004-07-08
HK1035896A1 (en) 2001-12-14
ATE268332T1 (de) 2004-06-15
EP1068210A2 (en) 2001-01-17
DK1068210T3 (da) 2004-09-20
KR20010034701A (ko) 2001-04-25
KR100613812B1 (ko) 2006-08-18
ES2222702T3 (es) 2005-02-01
JP4459439B2 (ja) 2010-04-28
IL138289A0 (en) 2001-10-31
WO1999051604A2 (en) 1999-10-14
GB9807116D0 (en) 1998-06-03
CA2323965A1 (en) 1999-10-14
BR9908959A (pt) 2000-12-05
US6437125B1 (en) 2002-08-20
EP1068210B1 (en) 2004-06-02
DE69917765T2 (de) 2005-07-14

Similar Documents

Publication Publication Date Title
KR0160144B1 (ko) 뉴클레오시드의 부분 입체 이성체를 선택적으로 합성하는 방법
CN1290841C (zh) 核苷类似物的非对映选择合成方法
CN1141305C (zh) 生产1,3-氧硫戊环核苷的方法
JPH08504212A (ja) 抗ウイルス特性を有する置換１，３‐オキサチオランを調製する方法
CN1153769C (zh) 嘌呤衍生物及其中间体以及该衍生物的制备方法
CN1125068C (zh) 嘌呤衍生物的制备方法
CN1120044A (zh) N-9取代的鸟嘌呤化合物的制备
JP2002510692A5 (https=)
KR101157468B1 (ko) 1,3-디옥솔란 뉴클레오시드 제조방법
HU202882B (en) New process for producing antiviral 6-deoxyguanine derivatives and intermediates thereof
CA2220995C (fr) Nouveaux derives 7,12-dioxa-benzo¬a|anthraceniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HK1035896B (en) Process for the production of purine derivatives
JP2005521660A (ja) ジオキソランヌクレオシド類似体の製造方法
HK1034512B (en) Process for the production of purine derivatives and intermediates therefor
JPH05271139A (ja) 被保護ホルミルシクロペンタンジオール類、ヒドロキシメチルシクロペンタンジオール類、それらの製造方法及び中間体類
CN1122805A (zh) 9-(2-羟乙氧基甲基)鸟嘌呤的制备方法

Legal Events

Date Code Title Description
BB1A Publication of application
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: BELLSOS INTELLECTUAL PROPERTY CO., LTD.

Free format text: FORMER OWNER: SMITHKLINE BEECHAM PLC

Effective date: 20010809

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20010809

Address after: Bermuda Hamilton

Applicant after: Novartis Int Pharm Ltd.

Address before: The British England Middlesex County

Applicant before: Smithkline Beecham PLC

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1050419

Country of ref document: HK

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20031022

Termination date: 20110330